In recent years the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more flexible and agile approach to early developability and method development. Lonza have developed a Toolbox approach using in silico tools, vector design/screening and analytical method development to de-risk process development and manufacturing. This toolbox approach allows us to screen for titre and product assembly at an early stage of development.

Authors: Rebecca Michael, PhD Principal Group Leader, Cell and Molecular Biology Group and Karl Rogerson Senior Principal Scientist, Global Process and Analytical Development Sciences

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center